Kiora Pharmaceuticals, Inc.

NasdaqCM:KPRX Stock Report

Market Cap: US$10.9m

Kiora Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:KPRX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Sep 24BuyUS$4,600Carmine StengoneIndividual1,250US$3.68
10 Sep 24BuyUS$10,800Aron ShapiroIndividual3,000US$3.60
19 Aug 24BuyUS$19,800Praveen TyleIndividual5,000US$3.96
19 Aug 24BuyUS$4,825Lisa Walters-HoffertIndividual1,250US$3.86
14 Aug 24BuyUS$6,420Melissa ToscaIndividual2,000US$3.21
14 Jun 24BuyUS$525Melissa ToscaIndividual100US$5.25
14 Jun 24BuyUS$7,570Eric DanielsIndividual1,431US$5.29
13 Jun 24BuyUS$25,669Erin ParsonsIndividual5,260US$4.88
13 Jun 24BuyUS$14,997Brian StremIndividual3,000US$5.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KPRX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders78,1102.6%
VC/PE Firms516,28617.2%
Institutions646,77121.6%
Hedge Funds755,98925.2%
General Public1,003,63233.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 251.2%.

Top Shareholders

Top 25 shareholders own 66.5% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.69%
Lincoln Park Capital, LLC
260,731US$946.5k0%49.17%
8.52%
Rosalind Advisors, Inc.
255,555US$927.7k0%0.53%
8.52%
Aigh Capital Management, LLC
255,555US$927.7k0%0.39%
7.04%
Nantahala Capital Management, LLC
211,110US$766.3k0%0.06%
6.74%
Stonepine Capital Management LLC
202,400US$734.7k1.2%0.26%
6.02%
Goldman Sachs Group, Investment Banking and Securities Investments
180,792US$656.3k0%no data
6.02%
Alyeska Investment Group, L.P.
180,780US$656.2k0%no data
5.39%
ADAR1 Capital Management, LLC
161,699US$587.0k-6.31%0.11%
4.07%
Velan Capital Partners LP
122,223US$443.7k0%0.41%
1.28%
Spearhead Insurance Solutions Idf, Llc
38,522US$139.8k0%6.96%
1.01%
Brian Strem
30,160US$109.5k108%no data
0.62%
Eric Daniels
18,577US$67.4k65.5%no data
0.48%
Geode Capital Management, LLC
14,483US$52.6k5.17%no data
0.45%
Melissa Tosca
13,599US$49.4k242%no data
0.38%
Susquehanna International Group, LLP, Asset Management Arm
11,382US$41.3k0%no data
0.34%
Citadel Advisors LLC
10,114US$36.7k0%no data
0.18%
Erin Parsons
5,260US$19.1k0%no data
0.17%
Praveen Tyle
5,014US$18.2k41,700%no data
0.17%
Sabby Management, LLC
5,000US$18.1k0%0.16%
0.1%
Aron Shapiro
3,000US$10.9k0%no data
0.091%
The Vanguard Group, Inc.
2,729US$9.9k0%no data
0.067%
Bridgeway Capital Management, LLC
2,000US$7.3k0%no data
0.065%
Tower Research Capital Europe Limited
1,954US$7.1k0%no data
0.054%
BlackRock, Inc.
1,606US$5.8k0%no data
0.042%
Lisa Walters-Hoffert
1,250US$4.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 03:57
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kiora Pharmaceuticals, Inc. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Keay NakaeChardan Capital Markets, LLC
Yi ChenH.C. Wainwright & Co.
Matthew KaplanLadenburg Thalmann & Company